Opt Health Vs Hone Health

Opt Health and Hone Health both bundle a clinician and both write prescriptions, which puts them on the same side of the category line. What separates them is width. Hone Health runs a hormone-focused panel from an at-home finger-prick kit and treats testosterone end to end from roughly $45 a month. Opt Health runs a 55+ marker venous panel across hormones, metabolic markers, inflammation, and nutrients at roughly $3,000 a year, with TRT as one of several possible outputs.

What each platform actually is

Opt Health

Opt Health sells one cash-pay membership at around $3,000 a year, aimed at adults over 40. Physicians run the clinical side, and the one-on-one consult is inside the price. Physically, you get a venous draw taken by an at-home phlebotomist in most markets, covering 55+ markers across hormones, metabolic function, inflammation, and nutrients, followed by a written protocol that can include testosterone replacement, peptides, a GLP-1, or supplements. Labs repeat every 3–4 months for every member and the protocol is adjusted against them. Opt Health does not operate in-person clinics, does not offer imaging, does not bill insurance, and does not include the price of any medication it prescribes.

Hone Health

Hone Health is the largest telehealth TRT platform in the US and sells a monthly membership from around $45, rising to $150–$220 or more on a full treatment protocol. The clinical side is telehealth clinicians working within a hormone-focused scope. Physically, you get a finger-prick collection kit mailed to you, a hormone panel returned in roughly 5–7 days, a clinician review of TRT candidacy, and, if prescribed, medication shipped to your door with quarterly retesting. Hone Health does not run a general longevity panel, does not carry GLP-1 pathways, offers limited peptide access, and bills medication separately from the membership.

Side by side on the standard rubric

The same nine criteria for both, using the figures each platform publishes.

What each actually costs

Opt Health carries a single annual figure with no stated one-time onboarding fee, so year two opens at the same ~$3,000. Everything above that number is pharmacy. TRT at $50–$200 a month adds $600–$2,400 across a year, a compounded GLP-1 at $200–$400 a month adds considerably more, and a protocol built on supplements and behavior change adds comparatively little. That is why the published year-one range stretches to $6,000 and beyond. Year two follows the protocol rather than the calendar: drop a medication and the ongoing total falls back toward the membership line with panel and consult cadence unchanged.

Hone Health prices by month, so the annual figure depends entirely on where you land. At the ~$45 tier a full year is about $540 and the platform functions as a hormone test with clinician review. At the $220 treatment tier a full year is about $2,640, which sits roughly $360 below Opt Health's membership before either platform's medication cost is counted. The ~$45 entry test is a one-time purchase, so year two is twelve months at whatever tier you settled on — meaning year two is cheaper than year one only for members who stopped treatment, and effectively flat for everyone who continued.

Where Opt Health leads

• Panel scope. 55+ markers cover thyroid, metabolic, inflammatory, and nutrient categories alongside hormones, in a single collection.
• Prescription breadth. Peptides, GLP-1 medications, and supplement protocols are available beyond TRT, from the same physician relationship.
• Venous draw at home. At-home phlebotomy in most markets supports a wide panel without requiring a trip to a collection site.
• Reassessment applies to everyone. The 3–4 month cadence runs whether or not a prescription was written, so non-treated members still get tracked.
• Physician consult included. A one-on-one session with a physician covering the full panel is part of the membership price.

Where Hone Health leads

• Collection method. A mailed finger-prick kit removes the appointment entirely — no phlebotomist to schedule and no market coverage to check.
• Entry price. Around $45 a month is the lowest way into a clinician-reviewed hormone assessment in this category.
• End-to-end TRT loop. Test, clinician review, prescription, and shipped medication all sit inside one platform with no handoff.
• Quarterly review for TRT patients. Members on testosterone are retested every three months, which is the cadence dose adjustment relies on.
• Scale and focus. As the largest telehealth TRT platform in the US, the whole flow is built around one clinical decision rather than adapted to it.

Trade-offs to weigh

Opt Health trade-offs

• Cost against the entry alternative. Roughly $3,000 a year is about five and a half times Hone Health's ~$540 test-and-membership tier, before medication on either side.
• You buy the scope regardless. A member who only wants testosterone assessed and treated is still paying for the metabolic, inflammatory, and nutrient work.
• The draw needs scheduling. A venous collection means arranging a phlebotomist visit and confirming your market is covered, where a mailed kit needs neither.
• Cash-pay, with pharmacy on top. No insurance channel exists, and every prescribed medication is charged separately from the ~$3,000.

Hone Health trade-offs

• Hormone-focused panel. Thyroid, metabolic, inflammatory, and nutrient contributors to fatigue and low libido sit outside the limited panel, so a low reading is interpreted without them.
• Capillary sample constrains the panel. A finger-prick collection returns a small volume, which caps how much can be assayed from one kit and is part of why the panel stays narrow.
• The entry price is not the treatment price. A full protocol moves the membership to $150–$220+ a month, and TRT medication is billed apart from that.
• Narrow prescription scope. TRT is the core pathway, peptide access is limited, and there is no GLP-1 route, so a metabolic finding leads outside the platform.

Who should pick each

Pick Opt Health if: you are over 40 with a symptom cluster rather than one symptom — energy, sleep, weight, mood, and libido moving together — and you want thyroid, insulin, inflammation, and nutrient status assessed alongside testosterone. You can carry roughly $3,000 before pharmacy, you want reassessment every 3–4 months regardless of what is prescribed, and you would rather one physician held the whole picture than treat hormones in isolation.

Pick Hone Health if: you are a man who has already narrowed the question to testosterone, you want the cheapest clinician-reviewed route to an answer, and you would rather mail a kit than schedule a draw. You accept a hormone-focused panel, you have a primary care relationship for anything outside it, and you want a monthly commitment you can stop rather than an annual membership decided up front.

Who should pick neither

Low testosterone is a diagnosis with covered pathways, and both platforms are cash-pay routes around them. If your symptoms are unexplained rather than already narrowed, or if cost is the binding constraint, start somewhere else.

• An in-network endocrinologist or urologist. Suspected hypogonadism can be worked up on insurance, including the repeat morning testosterone, LH, FSH, and prolactin testing that confirms or rules out a treatable cause.
• An in-network primary care workup. Fatigue and low libido are also produced by anaemia, hypothyroidism, depression, and sleep apnea, all diagnosable for a copay before any cash-pay membership.
• Marek Health and Maximus — listed alphabetically, the deeper a la carte and the alternative men's-hormone routes.
• Lifeforce — the mid-priced clinician-led membership between these two price bands.

Can you use both?

Stacking these two makes less sense than most pairings in the category, because the overlap is the expensive part. Both bundle a clinician and both prescribe testosterone, and two prescribers writing for the same therapy is a clinical problem rather than a redundancy you can afford to ignore. Running Opt Health's membership alongside Hone Health's treatment tier would cost roughly $5,600 a year before medication, and the second platform adds no test the first cannot run and no prescription the first cannot write.

The one sequence that holds up is using Hone Health's ~$45 entry test as a screen. It is a cheap way to see whether testosterone is low at all before deciding whether a 55+ marker membership is warranted. If the hormone result comes back unremarkable and symptoms persist, that is itself the argument for the wider panel — the cause is somewhere the hormone-focused kit does not look. If the result is low and testosterone is the only thing you want treated, you are already on the platform that treats it, and there is no reason to add the second.

What the rubric does not capture

The rubric says "bundled clinician" for both, which hides the difference in who that is and what they are looking at. Hone Health's telehealth clinicians work inside a hormone scope, so the review is about TRT candidacy and dose. Opt Health's physician consult is about the whole panel, so an elevated hsCRP or a low ferritin is in scope in the same conversation. Neither arrangement is more careful than the other. They are answering different questions, and a clinician who only holds part of the picture is not being negligent — they are being used for what they were engaged to do.

Month six looks different on each, and it is the point where people misjudge value. On Hone Health, a member stabilised on a maintenance dose is largely in a refill-and-quarterly-check relationship; the platform has done its job, and the monthly fee buys continuity rather than new information. On Opt Health, month six is a second or third reassessment, so the panel is generating new data whether or not anything changed. The first shape feels efficient when it is working and thin when it is not. The second feels thorough when something moves and expensive when nothing does.

Geography and logistics decide more of this than either page suggests. Hone Health's kit works anywhere a mail service reaches, which makes it the practical option in rural markets regardless of the rest of the comparison. Opt Health's at-home phlebotomy covers most markets, which is not all of them, and the venous panel is what the 55+ list requires. Before either comparison matters, check whether the collection method actually reaches your address — that single fact overrides most of the nine rows above it.

Related

• Full Opt Health review
• Full Hone Health review
• Opt Health cost breakdown
• Is Hone Health worth it?
• Hone Health vs Marek Health
• Opt Health vs Marek Health
• Maximus vs Hone Health
• All doctor-led options compared